INVITRO RELEASE OF NICOTINIC-ACID ALKYL ESTERS FROM POLOXAMER VEHICLES

被引:0
|
作者
WU, HLS [1 ]
MILLER, SC [1 ]
机构
[1] UNIV MINNESOTA,DEPT PHARMACEUT,MINNEAPOLIS,MN 55455
关键词
POLOXAMER; GELATION; NORMAL-ALKYL NICOTINATE; HLB; SOLUBILIZATION; DIFFUSION COEFFICIENT;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Poloxamers are poly(oxyethylene)poly(oxypropylene) block copolymers. Aqueous solutions of these polyols show reverse thermal gelation, low toxicity and good solubilization capacity. As such, they appear to be useful as components of topical drug delivery systems. The objectives of this study were to systematically investigate the effects of (1) poloxamer lipophilicity, (2) poloxamer concentration and (3) temperature on the in vitro release rate of drug from formulations containing hexyl nicotinate. Studies were conducted in a membrane-less model using isopropylmyristate as the receptor phase; for some studies, a series of n-alkyl nicotinates (methyl, ethyl, butyl and hexyl) were used as model compounds. Results indicated that the diffusion coefficients decreased with increasing poloxamer concentration and increased with increasing temperature. Results with different poloxamers indicated that the release rate increased with increasing poloxamer hydrophilic-lipophilic balance (HLB). The order of release rate for alkyl nicotinates was methyl > ethyl > butyl > > hexyl. The markedly lower release rate for hexyl nicotinate was explained by a stronger interaction between drug and poloxamer.
引用
下载
收藏
页码:213 / 221
页数:9
相关论文
共 50 条
  • [11] ABSORPTION OF NICOTINIC-ACID AND NICOTINAMIDE FROM RAT SMALL-INTESTINE INVITRO
    SADOOGHABASIAN, F
    EVERED, DF
    BIOCHIMICA ET BIOPHYSICA ACTA, 1980, 598 (02) : 385 - 391
  • [12] THE BIOAVAILABILITY OF SUSTAINED-RELEASE NICOTINIC-ACID FORMULATIONS
    NEUVONEN, PJ
    ROIVAS, L
    LAINE, K
    SUNDHOLM, O
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 32 (04) : 473 - 476
  • [13] DISPOSITION OF ETOFIBRATE, CLOFIBRIC AND NICOTINIC-ACID ESTERS, AND THEIR PRODUCTS IN DOGS
    GARRETT, ER
    ALTMAYER, P
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1985, 74 (03) : 295 - 299
  • [14] NICOTINIC-ACID AND DILUTION RATE EFFECTS ON INVITRO FERMENTATION EFFICIENCY
    SCHAETZEL, WP
    JOHNSON, DE
    JOURNAL OF ANIMAL SCIENCE, 1981, 53 (04) : 1104 - 1108
  • [15] UPTAKE OF NICOTINIC-ACID BY THE RAT INTESTINAL-MUCOSA INVITRO
    MIDDLETON, HM
    CLINICAL RESEARCH, 1983, 31 (05): : A871 - A871
  • [16] SYNTHESIS AND PHARMACOLOGICAL PROPERTIES OF SOME AMINOALKYL ESTERS OF NICOTINIC-ACID DERIVATIVES
    URBANSKA, H
    SWIRSKA, A
    BOGDAL, M
    PRZEMYK, B
    KRZYWOSINSKI, L
    ACTA POLONIAE PHARMACEUTICA, 1979, 36 (06): : 657 - 665
  • [17] NEW DIENAMINO ESTERS AND THEIR CYCLIZATION TO ALPHA-PYRIDONES OF NICOTINIC-ACID
    ANGHELIDE, N
    DRAGHICI, C
    RAILEANU, D
    TETRAHEDRON, 1974, 30 (05) : 623 - 632
  • [18] IMPROVED SYNTHESIS OF ARECOLINE FROM NICOTINIC-ACID
    KOZELLO, IA
    GASHEVA, AY
    KHMELEVSKY, VI
    KHIMIKO-FARMATSEVTICHESKII ZHURNAL, 1976, 10 (11): : 90 - 91
  • [19] STRUCTURE-REACTIVITY RELATIONSHIPS IN THE CHEMICAL HYDROLYSIS OF PRODRUG ESTERS OF NICOTINIC-ACID
    WERNLYCHUNG, GN
    MAYER, JM
    TSANTILIKAKOULIDOU, A
    TESTA, B
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1990, 63 (02) : 129 - 134
  • [20] INFLUENCE OF DIFFERENT VEHICLES ON THE BIOLOGICAL-ACTIVITY OF DISSOLVED NICOTINIC-ACID BENZYLESTER
    LIPPOLD, BC
    TEUBNER, A
    PHARMAZEUTISCHE INDUSTRIE, 1981, 43 (11): : 1123 - 1133